MOULDER LEON O JR

CIK 00012288654 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001228865

Recent Transactions

43 trades

Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-12-04$9.98/sh+45,000→ 241,155 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-12-03$10.76/sh+25,000→ 196,155 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+48,254→ 161,155 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+108,381→ 112,901 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+164,523→ 1,280,022 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series B Convertible Preferred Stock
2024-09-16−3,230,268→ 0 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+372,017→ 1,652,039 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series A Convertible Preferred Stock
2024-09-16−941,088→ 0 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series B Convertible Preferred Stock
2024-09-16−418,996→ 0 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series Seed Convertible Preferred Stock
2024-09-16−1,428,571→ 0 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2024-09-12+1,486,000→ 1,486,000 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2011-06-02+9,472→ 9,472 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2011-06-02+9,472→ 9,472 total
Award
CUBIST PHARMACEUTICALS INC
Common Stock
2011-06-02+578→ 883 total
Award
CUBIST PHARMACEUTICALS INC
Common Stock
2011-06-02+578→ 883 total
Award
Abraxis BioScience, Inc.
Restricted Stock Units
2009-04-29+50,000→ 50,000 total
Award
Abraxis BioScience, Inc.
Restricted Stock Units
2009-04-29+50,000→ 50,000 total
Award
Abraxis BioScience, Inc.
Stock Option (Right to Purchase)
2009-04-29$47.46/sh+200,000→ 200,000 total
Award
Abraxis BioScience, Inc.
Stock Option (Right to Purchase)
2009-04-29$47.46/sh+200,000→ 200,000 total
Tax Payment
MGI PHARMA INC
Common Stock
2007-08-31$23.57/sh−1,635→ 208,338 total
Tax Payment
MGI PHARMA INC
Common Stock
2007-08-31$23.57/sh−1,635→ 208,338 total
Tax Payment
MGI PHARMA INC
Common Stock
2007-05-10$21.14/sh−2,616→ 219,273 total
Tax Payment
MGI PHARMA INC
Common Stock
2007-05-10$21.14/sh−2,616→ 219,273 total
Tax Payment
MGI PHARMA INC
Common Stock
2006-07-15$20.58/sh−411→ 200,589 total
Tax Payment
MGI PHARMA INC
Common Stock
2006-07-15$20.58/sh−411→ 200,589 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.85/sh+500→ 200,800 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.85/sh+500→ 200,800 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.86/sh+200→ 201,000 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.84/sh+1,300→ 200,300 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.86/sh+200→ 201,000 total
Purchase
MGI PHARMA INC
Common Stock
2005-10-27$18.84/sh+1,300→ 200,300 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$3.65/sh−30,000→ 15,000 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$3.55/sh−25,000→ 12,500 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$3.65/sh+30,000→ 194,000 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$5.13/sh−15,000→ 37,500 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$5.13/sh+15,000→ 139,000 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$3.55/sh+25,000→ 164,000 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$3.55/sh−25,000→ 12,500 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$3.65/sh+30,000→ 194,000 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$5.13/sh+15,000→ 139,000 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$5.13/sh−15,000→ 37,500 total
Exercise/Conversion
MGI PHARMA INC
Employee Stock Option (right to buy)
2005-01-25$3.65/sh−30,000→ 15,000 total
Exercise/Conversion
MGI PHARMA INC
Common Stock
2005-01-25$3.55/sh+25,000→ 164,000 total

Companies

Recent Filings

Address

C/O ZENAS BIOPHARMA, INC. 852 WINTER STREET, SUITE 250

WALTHAM, MA, 02451

View on SEC.gov